» Articles » PMID: 27454043

Local Triple-combination Therapy Results in Tumour Regression and Prevents Recurrence in a Colon Cancer model

Overview
Journal Nat Mater
Date 2016 Jul 26
PMID 27454043
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

Conventional cancer therapies involve the systemic delivery of anticancer agents that neither discriminate between cancer and normal cells nor eliminate the risk of cancer recurrence. Here, we demonstrate that the combination of gene, drug and phototherapy delivered through a prophylactic hydrogel patch leads, in a colon cancer mouse model, to complete tumour remission when applied to non-resected tumours and to the absence of tumour recurrence when applied following tumour resection. The adhesive hydrogel patch enhanced the stability and provided local delivery of embedded nanoparticles. Spherical gold nanoparticles were used as a first wave of treatment to deliver siRNAs against Kras, a key oncogene driver, and rod-shaped gold nanoparticles mediated the conversion of near-infrared radiation into heat, causing the release of a chemotherapeutic as well as thermally induced cell damage. This local, triple-combination therapy can be adapted to other cancer cell types and to molecular targets associated with disease progression.

Citing Articles

Liposomal Nanocarriers to Enhance Skin Delivery of Chemotherapeutics in Cancer Therapy.

Liu X, Falconer R Bioengineering (Basel). 2025; 12(2).

PMID: 40001653 PMC: 11851846. DOI: 10.3390/bioengineering12020133.


Rise of implantable drugs: A chronicle of breakthroughs in drug delivery systems.

Huanbutta K, Puri V, Sharma A, Singh I, Sriamornsak P, Sangnim T Saudi Pharm J. 2024; 32(12):102193.

PMID: 39564378 PMC: 11570717. DOI: 10.1016/j.jsps.2024.102193.


Enhancing photothermal therapy of tumors with image-guided thermal control of gene-expressing bacteria.

Zeng F, Du M, Yang Y, Fang J, Wang Y, Goh M Theranostics. 2024; 14(15):5945-5964.

PMID: 39346533 PMC: 11426242. DOI: 10.7150/thno.98257.


3D-Printed Breast Prosthesis that Smartly Senses and Targets Breast Cancer Relapse.

Wang L, Ye C, Xue X, Xie M, Zhi Y, Feng X Adv Sci (Weinh). 2024; 11(46):e2402345.

PMID: 39308160 PMC: 11633491. DOI: 10.1002/advs.202402345.


Current advance of nanotechnology in diagnosis and treatment for malignant tumors.

Wang B, Hu S, Teng Y, Chen J, Wang H, Xu Y Signal Transduct Target Ther. 2024; 9(1):200.

PMID: 39128942 PMC: 11323968. DOI: 10.1038/s41392-024-01889-y.


References
1.
Sonpavde G . Bevacizumab in colorectal cancer. N Engl J Med. 2004; 351(16):1690-1. DOI: 10.1056/NEJM200410143511622. View

2.
Oliva N, Carcole M, Beckerman M, Seliktar S, Hayward A, Stanley J . Regulation of dendrimer/dextran material performance by altered tissue microenvironment in inflammation and neoplasia. Sci Transl Med. 2015; 7(272):272ra11. PMC: 4627493. DOI: 10.1126/scitranslmed.aaa1616. View

3.
Kountouras J, Zavos C, Chatzopoulos D . Therapy for colorectal cancer. N Engl J Med. 2005; 352(17):1820-1. DOI: 10.1056/NEJM200504283521720. View

4.
Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

5.
Kistler C . Colorectal-cancer incidence and mortality after screening. N Engl J Med. 2013; 369(24):2354. DOI: 10.1056/NEJMc1313116. View